Showing results (221-230 of 265) with videos related to
Sort By:
Pageof 27
Annals of Surgical Oncology|August 23, 2025
Comparison between Neoadjuvant Chemoradiotherapy and Chemotherapy for Patients with Resectable Pancreatic CancerTakashi Murakami, Ryusei Matsuyama, Masanori Oshi, et al.BMC Cancer|February 21, 2014
Identification of the collagen type 1 α 1 gene (COL1A1) as a candidate survival-related factor associated with hepatocellular carcinomaMasamichi Hayashi, Shuji Nomoto, Mitsuhiro Hishida, et al.International Journal of Oncology|September 10, 2015
Effectiveness of plasma treatment on pancreatic cancer cellsNorifumi Hattori, Suguru Yamada, Koji Torii, et al.International Journal of Oncology|February 13, 2015
CCNJ detected by triple combination array analysis as a tumor-related gene of hepatocellular carcinomaNao Takano, Mitsuhiro Hishida, Yoshikuni Inokawa, et al.Journal of Gastroenterology|January 6, 2022
Surgical results of non-ampullary duodenal cancer: a nationwide survey in JapanKenji Nakagawa, Masayuki Sho, Ken-Ichi Okada, et al.Oncology Letters|March 22, 2016
NRAGE promotes the malignant phenotype of hepatocellular carcinomaDai Shimizu, Mitsuro Kanda, Hiroyuki Sugimoto, et al.International Journal of Cancer|August 14, 2015
Function and diagnostic value of Anosmin-1 in gastric cancer progressionMitsuro Kanda, Dai Shimizu, Tsutomu Fujii, et al.Oncology Reports|December 25, 2013
Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinomaDai Shimizu, Mitsuro Kanda, Shuji Nomoto, et al.Oncology Letters|January 21, 2017
Prognostic relevance of SAMSN1 expression in gastric cancerMitsuro Kanda, Dai Shimizu, Satoshi Sueoka, et al.Annals of Surgical Oncology|June 21, 2022
Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9Masaya Yamanaka, Masamichi Hayashi, Fuminori Sonohara, et al.Pageof 27